Dec 16, 2025 09:01AM Oncolytics reports 33% response rate in colorectal cancer study

Dec 9, 2025 06:01PM Oncolytics reschedules shareholder meeting to vote on Nevada incorporation

Nov 20, 2025 04:07PM Oncolytics Biotech postpones shareholder meeting due to government shutdown

Nov 19, 2025 09:01AM Oncolytics Biotech gets FDA alignment on pancreatic cancer drug trial

Nov 17, 2025 06:52AM Oncolytics Biotech (ONCY) PT Raised to $10 at H.C. Wainwright

Oct 28, 2025 07:30AM Oncolytics reports 30% response rate in anal cancer trial

Sep 29, 2025 08:31AM Oncolytics Biotech outlines three-arm pancreatic cancer trial design

Sep 16, 2025 07:01AM Oncolytics Biotech expands GOBLET cancer trial to US sites

Sep 8, 2025 07:01AM Oncolytics reports colorectal cancer trial data, plans regulatory talks

Sep 2, 2025 09:11AM Oncolytics Biotech reports safety data for pelareorep in cancer patients

Aug 11, 2025 04:56PM Oncolytics Biotech shareholders elect eight directors at annual meeting

Jul 29, 2025 08:30AM Oncolytics plans FDA talks for pancreatic cancer drug trial

Jul 16, 2025 08:31AM Oncolytics Biotech reports pelareorep immunotherapy data across tumor types

Jul 10, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY)

Jul 8, 2025 08:35AM Oncolytics Biotech reports survival data for pelareorep cancer therapy

Jun 30, 2025 07:01AM Oncolytics Biotech (ONCY) Appoints Andrew Aromando as Chief Business Officer

May 14, 2025 04:27PM Oncolytics Biotech (ONCY) Tops Q1 EPS by 3c

Feb 18, 2025 04:07PM Oncolytics Biotech (ONCY) Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer

Feb 14, 2025 05:15PM Oncolytics Biotech (ONCY) Receives Nasdaq Non-compliance Notice

Feb 3, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY)

Jan 15, 2025 07:04AM Regulatory Approval Clears Path for Oncolytics Biotech (ONCY) to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data

Nov 12, 2024 07:40AM Oncolytics Biotech (ONCY) Misses Q3 EPS by 2c

Oct 4, 2024 07:00AM Oncolytics Biotech (ONCY) Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path

Sep 20, 2024 06:51AM H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY)

Sep 19, 2024 07:05AM Oncolytics Biotech (ONCY) Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study

Aug 21, 2024 06:46AM H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY)

Aug 12, 2024 07:50AM Sinovac Biotech (SVA) Announces Appointment of New CEO

Aug 1, 2024 05:20PM Oncolytics Biotech (ONCY) Reports In-Line Q2 EPS

Jun 27, 2024 07:01AM Oncolytics Biotech (ONCY) Announces Productive FDA Type C Meeting on its Metastatic Breast Cancer Program

Jun 24, 2024 07:01AM Oncolytics (ONCY) Announces Medical Leave of Absence of CEO